NBTX Dividend: Nanobiotix SA Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

NBTX Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	-14	-11	30	0	0	0
Revenue Growth (YoY)	-139%	-137%	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	20	20	21	17	19	14
Research & Development	32	39	37	31	29	23
Operating Expenses	51	56	56	46	52	36
Other Non Operating Income (Expenses)	--	0	0	0	0	0
Pretax Income	-51	-68	-39	-57	-46	-33
Income Tax Expense	0	0	0	0	0	0
Net Income	-51	-68	-39	-57	-47	-33
Net Income Growth	55%	74%	-32%	21%	42%	-34%
Shares Outstanding (Diluted)	47.41	47.26	36.92	34.85	34.73	24.38
Shares Change (YoY)	1%	28%	6%	0%	42%	13%
EPS (Diluted)	-1.08	-1.44	-1.07	-1.63	-1.35	-1.37
EPS Growth	53%	34%	-34%	21%	-2%	-41%
Free Cash Flow	-31	-20	-12	-37	-30	-27
Free Cash Flow Per Share	-0.65	-0.42	-0.32	-1.06	-0.86	-1.1
Gross Margin	--	--	--	--	--	--
Operating Margin	464.28%	618.18%	-86.66%	0%	0%	0%
Profit Margin	364.28%	618.18%	-130%	0%	0%	0%
Free Cash Flow Margin	221.42%	181.81%	-40%	0%	0%	0%
EBITDA	-64	-67	-25	-45	-51	-35
EBITDA Margin	457.14%	609.09%	-83.33%	0%	0%	0%
D&A For EBITDA	1	1	1	1	1	1
EBIT	-65	-68	-26	-46	-52	-36
EBIT Margin	464.28%	618.18%	-86.66%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%